Wednesday, October 9, 2013

Titan Pharmaceuticals Reports Confirmation of Meeting With FDA Regarding Probuphine (OTCBB:TTNP, OTCMKTS:CRWE)

ttnp

Titan Pharmaceuticals, Inc. (TTNP)

Today, TTNP surged (+2.76%) up +0.018 at $.689 with 152,996 shares in play thus far (ref. google finance Delayed: 2:02PM EDT October 1, 2013).

Titan Pharmaceuticals, Inc. previously reported that the U.S. Food and Drug Administration (FDA) has granted the request for a meeting to discuss Probuphine®. The meeting is scheduled for November 19, 2013. The FDA has designated this as a Type C meeting and has requested the submission of briefing materials by October 7, 2013.

Titan Pharmaceuticals, Inc. (TTNP) 5 day chart:

ttnpchart

crownequityholdings

Crown Equity Holdings Inc. (CRWE)

Today, CRWE has surged (+60.00%) up +0.0036 at $.0096 with 100,000 shares in play thus far (ref. google finance Delayed: 1:24PM EDT October 1, 2013).

CRWE daily range is at ($.01 – $.008) thus far and currently at $.0096 would be considered a (+772.72%) gain above the 52 wk low of $.0011.

Crown Equity Holdings Inc. (CRWE) 5 day chart:

crwechart

No comments:

Post a Comment